Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “United States Clinical Nutrition Market, Competition, Forecast and Opportunities, 2018-2028” report has been added to ResearchAndMarkets.com’s offering.
The United States Clinical Nutrition Market is poised for a significant expansion, with projections indicating a 7.52% Compound Annual Growth Rate (CAGR) from 2018 through 2028. According to recent analyses, the market, valued at USD 14.05 Billion in 2022, is set to continue its steady growth trajectory. Clinical nutrition, a concentrated branch of nutrition science, plays an indispensable role in managing diseases and preventing malnutrition-related consequences.
Benefits of Clinical Nutrition and Market Drivers
Clinical nutrition is paramount in reducing the impacts of malnutrition by enhancing disease treatment response and aiding in recovery, thus yielding improved health outcomes. It bolsters immunity levels and enhances ingestion capabilities, maximising nutrient absorption and intake. As the prevalence of metabolic disorders like diabetes and obesity increases in the United States, so does the necessity for clinical nutrition solutions. With its capability to address specific malnutrition issues and contribute to overall health, clinical nutrition’s demand is on the rise.
High Healthcare Expenditure Encourages Clinical Nutrition Growth
Significant healthcare spending by both government and private entities in the United States fuels the growth of the clinical nutrition market. Investments in preventive healthcare measures, such as clinical nutrition, are perceived as strategic actions to improve patient outcomes and decrease healthcare costs. The high incidence of chronic diseases and an aging population with specific nutritional needs are propelling the demand for specialized clinical nutrition care.
Segmental Insights Indicate Dominance of Enteral Nutrition and Oral Administration
Segmental analysis within the market shows substantial shares for both Enteral Nutrition due to its cost-effectiveness and user-friendly administration and the oral route of administration, owing to the convenience and non-invasiveness of oral intake. Both sectors are expected to continue their dominance, driven by enhancements in product formulations, ease of use, and increased life expectancy.
West Coast to Spearhead Regional Market Growth
Regionally, the West Coast is projected to lead the United States Clinical Nutrition Market, backed by its advanced healthcare infrastructure and growing elderly population. Investment in innovative clinical nutrition solutions, along with the presence of leading industry players in the region, positions the West Coast at the forefront of the clinical nutrition industry.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 77 |
| Forecast Period | 2022 – 2028 |
| Estimated Market Value (USD) in 2022 | $14.05 Billion |
| Forecasted Market Value (USD) by 2028 | $21.85 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | United States |
A selection of companies mentioned in this report includes
- Nestlé USA
- Danone North America
- Abbott U.S.
- Fresenius Kabi USA, LLC
- Baxter International Inc.
- B. Braun USA
- ConMed Corp
- Vesco Medical, LLC
- Pfizer Inc.
- Otsuka Pharmaceutical Companies
For more information about this report visit https://www.researchandmarkets.com/r/x3ndrr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- U.S. Clinical Nutrition Market
